Pharma Insider Sells 4,772 Shares as 2025 Revenue Hits $883M
A high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
Choosing between index funds and ETFs depends on trading needs, costs, and tax considerations. This guide outlines practical decision factors for you.
14,551 articlesA high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
Lilly stock has faced pressure, but one key driver could keep it in buy territory. This article unpacks the core reas...
Li Lu’s Himalaya Capital places a near alarmingly large bet on Alphabet, powering a dramatic year for the fund and re...
When homes linger on the market, buyers gain negotiating power and lenders adjust terms. This guide explains how stal...
Ibotta's Q1 2026 earnings reveal a company balancing rapid user growth with a longer road to sustainable profitabilit...
When a senior executive at Maze Therapeutics sells a stake after positive trial data and solid quarterly results, inv...
A 50-year-old professional earning $210,000 unveils a four-account plan to craft tax-free retirement income by 62, bl...
Investors are watching Lyft’s 2026 earnings closely to see if core growth, cost discipline, and smarter incentives ca...
BP weighs UK North Sea exits as part of a sweeping divestment plan, prompting debate over whether the group will stay...
A focused look at a standout semiconductor stock riding the AI wave. Learn what makes it different, how to evaluate i...
Axsome Therapeutics stock keeps climbing, hitting another high as regulatory news and a solid quarterly update bolste...
A security flaw allowed a hacker to drain approximately $5.9 million from TrustedVolumes, a DeFi liquidity provider o...